```
[Turn 3: Agent V3]
field: Analytical chemistry and experimental design (yield reporting standards, selectivity quantification, data completeness for communication-format papers)
field_rationale: S0-2 identifies mixed yield types (NMR assay, isolated), HTE-derived ee by SFC-MS, and selective quantitative disclosure (some products have full data, many have only descriptive language) as primary analytical features. The paper has no DFT-based energy profiles for transition states — only ground-state conformational calculations — so the computational trigger for V3 does not apply as strongly as the analytical/data-completeness trigger. V1 and V2 asked about chemical scope and mechanism; V3 asks whether the reported data are sufficient to independently evaluate the selectivity and yield claims, and whether the experimental design (HTE, scale, controls) is adequately described.

--- New questions ---

V3-Q1
loc: P44693–44694, Scheme 3*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Scheme 3 reports isolated yields for most substrates but NMR yields (footnote b) for an unspecified subset. The scheme does not individually indicate which compounds are footnote-b entries. Which specific compounds in Scheme 3 are reported as NMR yields rather than isolated yields, and what is the systematic reason (substrate instability, byproduct interference, scale limitation) for using NMR yields for those entries?
severity: high
inference_tier: T1

V3-Q2
loc: P44694, Scheme 3*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Products 21–24 are described only with qualitative performance descriptors ("high yield with excellent ee," "lower yield and enantioselectivity," "dramatic recovery[REDACTED: substantial verbatim quotation; see Tier 9]dramatic recovery" claim.
severity: high
inference_tier: T1

V3-Q3
loc: P44694, Scheme 3*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: Products 18 and 19 (tetrasubstituted alkene substrates) are described with comparative language ("high yield, somewhat lower ee"; "higher ee, more modest yield") but without numerical values. For products that demonstrate an important scope extension (tetrasubstituted alkenes) and a trade-off between yield and ee, quantitative data are necessary to assess the practical utility of the modified conditions.
severity: high
inference_tier: T1

V3-Q4
loc: P44693, Scheme 2 and Table 1*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The HTE optimization described prior to Table 1 is reported only as a summary conclusion (Pd(OAc)₂, MeCN, Bu₃N identified). No HTE data table is shown in the main text. How many conditions were screened in the initial HTE, and what yield/ee ranges were observed across the parameter space? The absence of primary HTE data prevents assessment of whether the optimization is complete or whether the landscape shows other competitive conditions.
severity: medium
inference_tier: T1

V3-Q5
loc: P44694, eq 2*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The absolute stereochemistry assignment relies on comparison of deprotected product 25 with a "known (S)-stereoisomer," but no optical rotation value, no literature citation for the reference compound, and no spectral comparison criteria are stated in the main text. What specific evidence (optical rotation, ¹H NMR comparison, X-ray) was used to confirm that 25 matches the known (S)-enantiomer?
severity: high
inference_tier: T1

V3-Q6
loc: P44695, Scheme 5*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: "Optical rotation matching the reported data" is the sole stated criterion for establishing that 30 is (R)-mephenytoin. What is the measured optical rotation and what literature value is it compared against? Additionally, hydrogenation could in principle affect ee if the alkene isomerization is reversible or if the substrate undergoes over-reduction — was the ee of 30 measured after hydrogenation?
severity: high
inference_tier: T1

V3-Q7
loc: P44693, Table 1*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: The HTE and Table 1 optimization use SFC-MS for ee determination of crude products, while the scope study (Scheme 3) appears to use SFC on purified products (based on standard scope-table practice). Are the ee values in Scheme 3 measured on crude or purified products? If on crude, is there potential for ee erosion during purification, or enhancement (e.g., preferential crystallization)? The measurement stage (crude vs. purified) is not stated in Scheme 3's caption.
severity: medium
inference_tier: T2 [paper-grounded inference]

V3-Q8
loc: P44694, Scheme 4*
quote: [REDACTED: see `loc:` above; full text in Tier 9]
question: "This was true in all cases examined" (product 26 racemic) — how many cases were examined and which substrates? The qualifier "in all cases examined" implies that not all scope substrates were checked for byproduct ee, and the number of cases examined is not stated.
severity: medium
inference_tier: T1

--- Overlaps with V1/V2 ---

V3-OV1 | overlaps_with: V1-Q6 | severity_V3: high | note: From an analytical standpoint, reporting comparative language ("high yield, somewhat lower ee") for compounds that demonstrate a key reaction variant (tetrasubstituted alkenes) violates the minimum data standard for a scope claim in a leading journal — quantitative data must be present to make the scope claim independently evaluable.

V3-OV2 | overlaps_with: V1-Q7 | severity_V3: high | note: Same analytical gap as V3-OV1 — four products (21–24) representing the critical N-substituent effect study have no quantitative yield or ee values in the main text; this prevents evaluation of the "dramatic recovery" selectivity claim.

V3-OV3 | overlaps_with: V1-Q10 | severity_V3: high | note: Absolute stereochemistry assignment by comparison with a known compound without citing the reference or providing comparison data is a standard violation in asymmetric synthesis reporting; both the reference literature value and the measured [α]D must appear in the main text or ESI and be cross-referenced.

V3-OV4 | overlaps_with: V2-Q4 | severity_V3: medium | note: From an experimental design perspective, the DFT calculations cited for conformational analysis (s-cis/s-trans energy differences) use ground-state energies without TS barriers — this is a computational methodology limitation; without the TS energies the calculation cannot actually predict whether cyclization should occur, making it supportive illustration rather than predictive evidence.
```

---

> **Tier 8 redaction notice**: This file is a redacted copy of the corresponding Tier 3 / Tier 9 output. Verbatim source-paper quotations have been replaced by `[REDACTED: see source paper §<loc>; full text retained in Tier 9 reviewer-only deposit]` markers, preserving location references and our own analytical content. Bibliographic fields (title, authors, journal, year, DOI), analytical labels (`evidence_chain:` with B-/U-/A-/C- internal IDs), short technical terms, and our own analytical text are not redacted. The redaction was applied by `scripts/redact_for_tier8.py` and, for this version, by `scripts/build_paperA_R1_public.py` with `scripts/redact_source_ngram_runs.py` (scripts of the project repository; they are not deposited).
